15家江苏创新药公司Q2获融资!

创鉴汇
09 Jul

江苏省作为中国生物医药产业的核心聚集区,在2025年第二季度展现出显著的创新活力。该季度共披露15起创新药公司融资事件,覆盖肿瘤、代谢疾病、中枢神经系统等多个领域,从地域分布看,苏州(7家)、南京(5家)成为融资主力。其中6起事件公开融资金额总计超96亿元,突显资本对江苏生物医药研发的持续投入。3家公司完成港股IPO:恒瑞医药、派格生物、药捷安康登陆港交所,分别募资约98.9亿港元、约2.32...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10